Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Expression of the endoplasmic reticulum molecular chaperone (ORP150) rescues hippocampal neurons from glutamate toxicity
Yasuko Kitao, … , Osamu Hori, Satoshi Ogawa
Yasuko Kitao, … , Osamu Hori, Satoshi Ogawa
Published November 15, 2001
Citation Information: J Clin Invest. 2001;108(10):1439-1450. https://doi.org/10.1172/JCI12978.
View: Text | PDF
Article

Expression of the endoplasmic reticulum molecular chaperone (ORP150) rescues hippocampal neurons from glutamate toxicity

  • Text
  • PDF
Abstract

A series of events initiated by glutamate-receptor interaction perturbs cellular homeostasis resulting in elevation of intracellular free calcium and cell death. Cells subject to such environmental change express stress proteins, which contribute importantly to maintenance of metabolic homeostasis and viability. We show that an inducible chaperone present in endoplasmic reticulum (ER), the 150-kDa oxygen-regulated protein (ORP150), is expressed both in the human brain after seizure attack and in mouse hippocampus after kainate administration. Using mice heterozygous for ORP150 deficiency, exposure to excitatory stimuli caused hippocampal neurons to display exaggerated elevation of cytosolic calcium accompanied by activation of μ-calpain and cathepsin B, as well as increased vulnerability to glutamate-induced cell death in vitro and decreased survival to kainate in vivo. In contrast, targeted neuronal overexpression of ORP150 suppressed each of these events and enhanced neuronal and animal survival in parallel with diminished seizure intensity. Studies using cultured hippocampal neurons showed that ORP150 regulates cytosolic free calcium and activation of proteolytic pathways causing cell death in neurons subject to excitatory stress. Our data underscore a possible role for ER stress in glutamate toxicity and pinpoint a key ER chaperone, ORP150, which contributes to the stress response critical for neuronal survival.

Authors

Yasuko Kitao, Kentaro Ozawa, Mayuki Miyazaki, Michio Tamatani, Tomohiro Kobayashi, Hideki Yanagi, Masaru Okabe, Masahito Ikawa, Tetsumori Yamashima, David M. Stern, Osamu Hori, Satoshi Ogawa

×

Figure 5

Options: View larger image (or click on image) Download as PowerPoint
Role of ORP150 in the neuronal response to kainate. Either Nissl (a–k) o...
Role of ORP150 in the neuronal response to kainate. Either Nissl (a–k) or immunostaining (l–t) of MAP2 was performed in each mouse type 12 hours after the intraventricular administration of kainate (0–0.4 μg). (a–i) and (l–t) ×400. Quantitative analysis of neuronal viability from CA-1 and CA-3 are added (j and k and u and v) in each case. Mean ± SD is shown (n = 8). *, ** P < 0.01 by multiple contrast analysis compared with wild-type mice. (w–y) Survival 24 hours after intraperitoneal administration of kainate (w). Occurrence of seizures (x) and seizure index (y) 4 hours after kainate were assessed as described. Mean ± SD is shown (n = 6). #, ## symbols indicate P < 0.01 by χ2 analysis compared with wild type mice. *, ** P < 0.01 by multiple contrast analysis following Kruskal-Wallis analysis compared with wild-type mice.

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts